Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-15-074683)

Filing Details

Accession Number:
0001209191-15-074683
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-07 17:27:48
Reporting Period:
2015-10-05
Filing Date:
2015-10-07
Accepted Time:
2015-10-07 17:27:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1328143 Adamas Pharmaceuticals Inc ADMS Pharmaceutical Preparations (2834) 421560076
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1266427 M Ivan Lieberburg C/O Adamas Pharmaceuticals, Inc.
1900 Powell St., Suite 750
Emeryville CA 94608		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-10-05 3,000 $16.75 54,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 16,000 Indirect Ivan Lieberburg and Janice Kirsch as CPWTROS
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.